AK
Anil Kumar Singh
About Anil Kumar Singh
Anil Kumar Singh has 19 years in corporate governance. Holds Additional Director and Managing Director roles. Currently with 2 companies, including Virgiliant Healthcare Private Limited and Sarika Construction Private Limited. Formerly with 1 company, such as Three Life Pharmaceutical Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Virgiliant Healthcare Private Limited
U24239BR2019PTC043031
|
Additional Director | 22 Sep 2020 | 2019 | Active |
Sarika Construction Private Limited
U45201BR2007PTC013058
|
Managing Director | 12 Jun 2007 | 2007 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Three Life Pharmaceutical Private Limited
U51900BR2016PTC031393
|
Director | 21 Apr 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Singh
Anil Kumar Singh has 19 years in corporate governance. Holds Additional Director and Managing Director roles. Currently with 2 companies, including Virgiliant Healthcare Private Limited and Sarika Construction Private Limited. Formerly with 1 company, such as Three Life Pharmaceutical Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Anil Kumar Singh is associated with 2 companies as Additional Director and Managing Director.
Anil Kumar Singh has expertise in Healthcare, General Business.
Anil Kumar Singh has 19 years in corporate governance.